GSK plans £2 billion share buyback, boosts long-term outlook
The buyback comes after GSK saw earnings per share, excluding some items, at 23.2 pence in the fourth quarterGSK plans ...
Tag: GSK
GSK to buy US cancer biotech IDRx for up to US$1.15 billion
GSK agreed to buy US biotech IDRx for as much as US$1.15 billion to gain new cancer medicines. The UK drugmaker ...
GSK surges 6.5% after US$2.2 billion Zantac lawsuits settlement
SHARES of British drugmaker GSK rose as much as 6.5 per cent on Thursday (Oct 10), after it agreed to ...
GSK raises annual profit and sales forecast after second quarter beat
BRITISH drugmaker GSK raised its annual earnings and sales forecasts on Wednesday (Jul 31) and posted second-quarter results that beat ...
UK government snubs GSK in favour of rival RSV shot from Pfizer
The decision is a blow to GSK, which is locked in fierce competition with Pfizer to corner the new market ...
GSK plunges as drugmaker must face Zantac cases in Delaware
Citi estimates Zantac settlement costs at US$3 billionGSK shares plunged in the wake of a court ruling that the UK ...
GSK profit drops in first quarter on higher costs
BRITISH drugmaker GlaxoSmithKline (GSK) on Wednesday (May 1) said its net profit fell 23 per cent in the first quarter ...
GSK profit drops 23% in Q1 on higher costs
BRITISH drugmaker GlaxoSmithKline (GSK) on Wednesday (May 1) said that its net profit fell 23 per cent in the first ...
Forbes 40under40 stands as a distinguished platform revered for its commitment to honoring and applauding the remarkable achievements of exceptional individuals who have yet to reach the age of 40. This esteemed initiative serves as a beacon of inspiration, spotlighting trailblazers across various industries and domains, showcasing their innovation, leadership, and impact on a global scale.
© 2024 Forbes 40under40. All Rights Reserved.